Agency Information Collection Activities: Proposed Collection; Comment Request, 11359-11361 [2017-03463]
Download as PDF
Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices
as a group acting in concert, to acquire
voting shares of Citizens Bancshares,
Inc. Walnut, Illinois, and thereby
indirectly acquire shares of Citizens
First State Bank of Walnut, Walnut,
Illinois.
B. Federal Reserve Bank of
Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Patrick Artz, Richard Kornkven,
and Monte Mikkelsen, all of Bottineau,
North Dakota; to each acquire voting
shares of State Bank of Bottineau
Holding Company, Bottineau, North
Dakota, and thereby indirectly acquire
shares of State Bank of Bottineau,
Bottineau, North Dakota.
Board of Governors of the Federal Reserve
System, February 15, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–03376 Filed 2–21–17; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
sradovich on DSK3GMQ082PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
VerDate Sep<11>2014
16:05 Feb 21, 2017
Jkt 241001
Governors not later than March 14,
2017.
A. Federal Reserve Bank of
Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. First Interstate BancSystem, Inc.,
Billings, Montana; to acquire 100
percent of Cascade Bancorp, Inc., Bend,
Oregon, and thereby acquire Bank of the
Cascades, Bend, Oregon.
Board of Governors of the Federal Reserve
System, February 16, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–03450 Filed 2–21–17; 8:45 am]
11359
1. Pinnacle Financial Partners, Inc.,
Nashville, Tennessee; to merge with
BNC Bancorp, High Point, North
Carolina, and thereby acquire Bank of
North Carolina, Thomasville, North
Carolina.
Board of Governors of the Federal Reserve
System, February 15, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–03375 Filed 2–21–17; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6210–01–P
Agency for Healthcare Research and
Quality
FEDERAL RESERVE SYSTEM
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than March 13,
2017.
A. Federal Reserve Bank of Atlanta
(Chapelle Davis, Assistant Vice
President) 1000 Peachtree Street NE.,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) to review again proposed
information collection project:
Pharmacy Survey on Patient Safety
Culture Comparative Database.’’ This
proposed information collection was
previously published in the Federal
Register on November 18, 2016 and
allowed 60 days for public comment.
AHRQ did not receive any substantive
comments. The purpose of this notice is
to allow an additional 30 days for public
comment.
DATES: Comments on this notice must be
received by March 24, 2017.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
email at OIRA_submission@
omb.eop.gov (attention: AHRQ’s desk
officer).
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Pharmacy Survey on Patient Safety
Culture Comparative Database
In 1999, the Institute of Medicine
called for health care organizations to
develop a ‘‘culture of safety’’ such that
their workforce and processes focus on
improving the reliability and safety of
E:\FR\FM\22FEN1.SGM
22FEN1
sradovich on DSK3GMQ082PROD with NOTICES
11360
Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices
care for patients (IOM, 1999; To Err is
Human: Building a Safer Health
System). To respond to the need for
tools to assess patient safety culture in
health care, AHRQ developed and pilot
tested the Pharmacy Survey on Patient
Safety Culture with OMB approval
(OMB NO. 0935–0183; Approved 08/12/
2011). The survey is designed to enable
pharmacies to assess staff opinions
about patient and medication safety and
quality-assurance issues, and includes
36 items that measure 11 dimensions of
patient safety culture. AHRQ made the
survey publicly available along with a
Survey User’s Guide and other toolkit
materials in October 2012 on the AHRQ
Web site.
The AHRQ Pharmacy Survey on
Patient Safety Culture (Pharmacy SOPS)
Comparative Database consists of data
from the AHRQ Pharmacy SOPS
Pharmacies in the U.S. are asked to
voluntarily submit data from the survey
to AHRQ, through its contractor, Westat.
The Pharmacy SOPS Database is
modeled after three other SOPS
databases: Hospital SOPS [OMB NO.
0935–0162; Approved 05/04/2010];
Medical Office SOPS [OMB NO. 0935–
0196; Approved 06/12/12]; and Nursing
Home SOPS [OMB NO. 0935–0195;
Approved 06/12/12] that were originally
developed by AHRQ in response to
requests from hospitals, medical offices,
and nursing homes interested in
knowing how their patient safety
culture survey results compare to those
of other similar health care
organizations.
Rationale for the information
collection. The Pharmacy SOPS survey
and the Pharmacy SOPS Comparative
Database will support AHRQ’s goals of
promoting improvements in the quality
and safety of health care in pharmacy
settings. The survey, toolkit materials,
and comparative database results are all
made publicly available on AHRQ’s
Web site. Technical assistance is
provided by AHRQ through its
contractor at no charge to pharmacies, to
facilitate the use of these materials for
pharmacy patient safety and quality
improvement.
Request for information collection
approval: AHRQ requests that the OMB
reapprove, under the Paperwork
Reduction Act of 1995, AHRQ’s
collection of information for the AHRQ
Pharmacy SOPS Comparative Database;
OMB NO. 0935–0218, last approved on
June 12, 2014.
This database will:
(1) Allow pharmacies to compare
their patient safety culture survey
results with those of other pharmacies,
(2) Provide data to pharmacies to
facilitate internal assessment and
VerDate Sep<11>2014
16:05 Feb 21, 2017
Jkt 241001
learning in the patient safety
improvement process, and
(3) Provide supplemental information
to help pharmacies identify their
strengths and areas with potential for
improvement in patient safety culture.
This study is being conducted by
AHRQ through its contractor, Westat,
pursuant to AHRQ’s statutory authority
to conduct and support research on
health care and on systems for the
delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of health care
services; quality measure and
development, and database
development. 42 U.S.C. 299a(a)(1), (2),
and 8.
Method of Collection
To achieve the goal of this project the
following activities and data collections
will be implemented:
(1) Pharmacy Eligibility and
Registration Form—The point of contact
(POC), often the pharmacy manager of a
participating organization, completes a
number of data submission steps and
forms, beginning with completion of an
online Eligibility and Registration Form.
The purpose of this form is to collect
basic demographic information about
the pharmacy and initiate the
registration process.
(2) Data Use Agreement—The purpose
of the data use agreement, completed by
the pharmacy POC, is to state how data
submitted by pharmacies will be used
and provides confidentiality assurances.
(3) Pharmacy Site Information Form—
The purpose of this form, completed by
the pharmacy POC, is to collect
background characteristics of the
pharmacy. This information will be
used to analyze data collected with the
Pharmacy SOPS survey.
(4) Data Files Submission—POCs
upload their data file(s), using the
community pharmacy or hospital
pharmacy data file specifications, to
ensure that users submit standardized
and consistent data in the way variables
are named, coded, and formatted.
The number of submissions to the
database is likely to vary each year
because pharmacies do not administer
the survey and submit data every year.
Data submission is typically handled by
one POC who is either a pharmacy
manager or a survey vendor who
contracts with a pharmacy to collect and
submit its data. POCs submit data on
behalf of 3 pharmacies, on average,
because many pharmacies are part of a
multi-pharmacy system, or the POC is a
vendor that is submitting data for
multiple pharmacies.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Survey data from the AHRQ
Pharmacy SOPS are used to produce
three types of products: (1) A Pharmacy
SOPS Comparative Database Report that
is made publicly available on the AHRQ
Web site (see https://www.ahrq.gov/
professionals/quality-patient-safety/
patientsafetyculture/pharmacy/pharmreports.html), (2) Individual Pharmacy
Survey Feedback Reports that are
confidential, customized reports
produced for each pharmacy that
submits data to the database (the
number of reports produced is based on
the number of pharmacies submitting
each year); and (3) Research data sets of
individual-level and pharmacy-level deidentified data to enable researchers to
conduct analyses.
Pharmacies are asked to voluntarily
submit their Pharmacy SOPS survey
data to the comparative database. The
data are then cleaned and aggregated
and used to produce a Comparative
Database Report that displays averages,
standard deviations, and percentile
scores on the survey’s 36 items and 11
patient safety culture dimensions, as
well as displaying these results by
pharmacy characteristics (pharmacy
type, number of locations, average
number of prescriptions dispensed per
week, etc.) and respondent
characteristics (staff position, tenure,
and hours worked per week).
Data submitted by pharmacies are also
used to give each pharmacy its own
customized survey feedback report that
presents the pharmacy’s results
compared to the latest comparative
database results. If a pharmacy submits
data more than once, its survey feedback
report also presents trend data,
comparing its previous and most recent
data.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondents’ time to participate in the
database. An estimated 100 POCs from
community pharmacies and 50 POCs
from hospital pharmacies, each
representing an average of 3 individual
pharmacies, will complete the database
submission steps and forms. Completing
the eligibility and registration form will
take about 5 minutes. The Pharmacy
Site Information Form is completed by
all POCs for each of their pharmacies
(150 × 3 = 450 forms in total) and is
estimated to take 5 minutes to complete.
Each POC will complete a data use
agreement which takes 3 minutes to
complete and submitting the data will
take an hour on average. The total
burden is estimated to be 209 hours.
Exhibit 2 shows the estimated
annualized cost burden based on the
E:\FR\FM\22FEN1.SGM
22FEN1
11361
Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices
respondents’ time to submit their data.
The cost burden is estimated to be
$11,222 annually.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents/
POCs
Form name
Number of
responses
per POC
Hours per
response
Total burden
hours
Eligibility and Registration Form ......................................................................
Data Use Agreement .......................................................................................
Pharmacy Site Information Form .....................................................................
Data Files Submission .....................................................................................
150
150
150
150
1
1
3
1
5/60
3/60
5/60
1
13
8
38
150
Total ..........................................................................................................
NA
NA
NA
209
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents/
POCs
Form name
Total burden
hours
Average
hourly
wage rate *
Total cost
burden
Eligibility and Registration Form ......................................................................
Data Use Agreement .......................................................................................
Pharmacy Site Information Form .....................................................................
Data Files Submission .....................................................................................
150
150
150
150
13
8
38
150
$53.69
53.69
53.69
53.69
$698
430
2,040
8,054
Total ..........................................................................................................
NA
209
NA
11,222
* Based on the weighted average hourly wage in community pharmacies for 100 General and Operations Managers (11–1021; $49.26) and 50
General and Operations Managers (11–1021; $62.56) obtained from the May 2015 National Industry-Specific Occupational Employment and
Wage Estimates: NAICS 446110—Pharmacies and Drug Stores (located at https://www.bls.gov/oes/current/naics5_446110.htm) and NAICS
622000—Hospitals (located at https://www.bls.gov/oes/current/naics3_622000.htm).
sradovich on DSK3GMQ082PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
AHRQ invites the public to comment on
this proposed information collection.
This is a second review opportunity.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
VerDate Sep<11>2014
16:05 Feb 21, 2017
Jkt 241001
comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–03463 Filed 2–21–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment; 60 Day
Proposed Information Collection:
Mashpee Wampanoag Indian Health
Service Unit Community Health
Assessment
AGENCY:
Indian Health Service, HHS.
Notice and request for
comments.
ACTION:
In compliance with the
Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the
general public to take this opportunity
to comment on the new information
collection Office of Management and
Budget (OMB) Control Number 0917–
NEW, titled, ‘‘Mashpee Wampanoag
Community Health Assessment.’’ The
purpose of this notice is to allow 60
days for public comment to be
submitted directly to OMB. A copy of
the draft supporting statement is
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
available at www.regulations.gov (see
Docket ID [IHS–2017–0001]).
DATES: April 24, 2017. Your comments
regarding this information collection are
best assured of having full effect if
received within 60 days of the date of
this publication.
ADDRESSES: Send your written
comments, requests for more
information on the collection, or
requests to obtain a copy of the data
collection instrument and instructions
to Rita Gonsalves by one of the
following methods:
• Mail: Ms. Rita Gonsalves, CEO,
Mashpee Wampanoag Health Service
Unit, Indian Health Service, 483B Great
Neck Rd. South, Mashpee, MA 02346.
• Phone: 508–477–6913.
• Email: Rita.Gonsalves@ihs.gov.
• Fax: 508–477–0156.
SUPPLEMENTARY INFORMATION: The
Indian Health Service Mashpee
Wampanoag Service Unit is submitting
the proposed information collection to
OMB for review, as required by section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995. This notice is
soliciting comments from members of
the public and affected agencies as
required by 44 U.S.C. 3506(c)(2)(A)
concerning the proposed collection of
information to: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
E:\FR\FM\22FEN1.SGM
22FEN1
Agencies
[Federal Register Volume 82, Number 34 (Wednesday, February 22, 2017)]
[Notices]
[Pages 11359-11361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03463]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) to review again proposed information
collection project: Pharmacy Survey on Patient Safety Culture
Comparative Database.'' This proposed information collection was
previously published in the Federal Register on November 18, 2016 and
allowed 60 days for public comment. AHRQ did not receive any
substantive comments. The purpose of this notice is to allow an
additional 30 days for public comment.
DATES: Comments on this notice must be received by March 24, 2017.
ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by
email at OIRA_submission@omb.eop.gov (attention: AHRQ's desk officer).
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Pharmacy Survey on Patient Safety Culture Comparative Database
In 1999, the Institute of Medicine called for health care
organizations to develop a ``culture of safety'' such that their
workforce and processes focus on improving the reliability and safety
of
[[Page 11360]]
care for patients (IOM, 1999; To Err is Human: Building a Safer Health
System). To respond to the need for tools to assess patient safety
culture in health care, AHRQ developed and pilot tested the Pharmacy
Survey on Patient Safety Culture with OMB approval (OMB NO. 0935-0183;
Approved 08/12/2011). The survey is designed to enable pharmacies to
assess staff opinions about patient and medication safety and quality-
assurance issues, and includes 36 items that measure 11 dimensions of
patient safety culture. AHRQ made the survey publicly available along
with a Survey User's Guide and other toolkit materials in October 2012
on the AHRQ Web site.
The AHRQ Pharmacy Survey on Patient Safety Culture (Pharmacy SOPS)
Comparative Database consists of data from the AHRQ Pharmacy SOPS
Pharmacies in the U.S. are asked to voluntarily submit data from the
survey to AHRQ, through its contractor, Westat. The Pharmacy SOPS
Database is modeled after three other SOPS databases: Hospital SOPS
[OMB NO. 0935-0162; Approved 05/04/2010]; Medical Office SOPS [OMB NO.
0935-0196; Approved 06/12/12]; and Nursing Home SOPS [OMB NO. 0935-
0195; Approved 06/12/12] that were originally developed by AHRQ in
response to requests from hospitals, medical offices, and nursing homes
interested in knowing how their patient safety culture survey results
compare to those of other similar health care organizations.
Rationale for the information collection. The Pharmacy SOPS survey
and the Pharmacy SOPS Comparative Database will support AHRQ's goals of
promoting improvements in the quality and safety of health care in
pharmacy settings. The survey, toolkit materials, and comparative
database results are all made publicly available on AHRQ's Web site.
Technical assistance is provided by AHRQ through its contractor at no
charge to pharmacies, to facilitate the use of these materials for
pharmacy patient safety and quality improvement.
Request for information collection approval: AHRQ requests that the
OMB reapprove, under the Paperwork Reduction Act of 1995, AHRQ's
collection of information for the AHRQ Pharmacy SOPS Comparative
Database; OMB NO. 0935-0218, last approved on June 12, 2014.
This database will:
(1) Allow pharmacies to compare their patient safety culture survey
results with those of other pharmacies,
(2) Provide data to pharmacies to facilitate internal assessment
and learning in the patient safety improvement process, and
(3) Provide supplemental information to help pharmacies identify
their strengths and areas with potential for improvement in patient
safety culture.
This study is being conducted by AHRQ through its contractor,
Westat, pursuant to AHRQ's statutory authority to conduct and support
research on health care and on systems for the delivery of such care,
including activities with respect to the quality, effectiveness,
efficiency, appropriateness and value of health care services; quality
measure and development, and database development. 42 U.S.C.
299a(a)(1), (2), and 8.
Method of Collection
To achieve the goal of this project the following activities and
data collections will be implemented:
(1) Pharmacy Eligibility and Registration Form--The point of
contact (POC), often the pharmacy manager of a participating
organization, completes a number of data submission steps and forms,
beginning with completion of an online Eligibility and Registration
Form. The purpose of this form is to collect basic demographic
information about the pharmacy and initiate the registration process.
(2) Data Use Agreement--The purpose of the data use agreement,
completed by the pharmacy POC, is to state how data submitted by
pharmacies will be used and provides confidentiality assurances.
(3) Pharmacy Site Information Form--The purpose of this form,
completed by the pharmacy POC, is to collect background characteristics
of the pharmacy. This information will be used to analyze data
collected with the Pharmacy SOPS survey.
(4) Data Files Submission--POCs upload their data file(s), using
the community pharmacy or hospital pharmacy data file specifications,
to ensure that users submit standardized and consistent data in the way
variables are named, coded, and formatted.
The number of submissions to the database is likely to vary each
year because pharmacies do not administer the survey and submit data
every year. Data submission is typically handled by one POC who is
either a pharmacy manager or a survey vendor who contracts with a
pharmacy to collect and submit its data. POCs submit data on behalf of
3 pharmacies, on average, because many pharmacies are part of a multi-
pharmacy system, or the POC is a vendor that is submitting data for
multiple pharmacies.
Survey data from the AHRQ Pharmacy SOPS are used to produce three
types of products: (1) A Pharmacy SOPS Comparative Database Report that
is made publicly available on the AHRQ Web site (see https://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/pharmacy/pharm-reports.html), (2) Individual Pharmacy Survey Feedback
Reports that are confidential, customized reports produced for each
pharmacy that submits data to the database (the number of reports
produced is based on the number of pharmacies submitting each year);
and (3) Research data sets of individual-level and pharmacy-level de-
identified data to enable researchers to conduct analyses.
Pharmacies are asked to voluntarily submit their Pharmacy SOPS
survey data to the comparative database. The data are then cleaned and
aggregated and used to produce a Comparative Database Report that
displays averages, standard deviations, and percentile scores on the
survey's 36 items and 11 patient safety culture dimensions, as well as
displaying these results by pharmacy characteristics (pharmacy type,
number of locations, average number of prescriptions dispensed per
week, etc.) and respondent characteristics (staff position, tenure, and
hours worked per week).
Data submitted by pharmacies are also used to give each pharmacy
its own customized survey feedback report that presents the pharmacy's
results compared to the latest comparative database results. If a
pharmacy submits data more than once, its survey feedback report also
presents trend data, comparing its previous and most recent data.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours for the
respondents' time to participate in the database. An estimated 100 POCs
from community pharmacies and 50 POCs from hospital pharmacies, each
representing an average of 3 individual pharmacies, will complete the
database submission steps and forms. Completing the eligibility and
registration form will take about 5 minutes. The Pharmacy Site
Information Form is completed by all POCs for each of their pharmacies
(150 x 3 = 450 forms in total) and is estimated to take 5 minutes to
complete. Each POC will complete a data use agreement which takes 3
minutes to complete and submitting the data will take an hour on
average. The total burden is estimated to be 209 hours.
Exhibit 2 shows the estimated annualized cost burden based on the
[[Page 11361]]
respondents' time to submit their data. The cost burden is estimated to
be $11,222 annually.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Number of
Form name respondents/ responses per Hours per Total burden
POCs POC response hours
----------------------------------------------------------------------------------------------------------------
Eligibility and Registration Form............... 150 1 5/60 13
Data Use Agreement.............................. 150 1 3/60 8
Pharmacy Site Information Form.................. 150 3 5/60 38
Data Files Submission........................... 150 1 1 150
---------------------------------------------------------------
Total....................................... NA NA NA 209
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of
Form name respondents/ Total burden Average hourly Total cost
POCs hours wage rate * burden
----------------------------------------------------------------------------------------------------------------
Eligibility and Registration Form............... 150 13 $53.69 $698
Data Use Agreement.............................. 150 8 53.69 430
Pharmacy Site Information Form.................. 150 38 53.69 2,040
Data Files Submission........................... 150 150 53.69 8,054
---------------------------------------------------------------
Total....................................... NA 209 NA 11,222
----------------------------------------------------------------------------------------------------------------
* Based on the weighted average hourly wage in community pharmacies for 100 General and Operations Managers (11-
1021; $49.26) and 50 General and Operations Managers (11-1021; $62.56) obtained from the May 2015 National
Industry-Specific Occupational Employment and Wage Estimates: NAICS 446110--Pharmacies and Drug Stores
(located at https://www.bls.gov/oes/current/naics5_446110.htm) and NAICS 622000--Hospitals (located at https://www.bls.gov/oes/current/naics3_622000.htm).
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ health care research and
health care information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information upon the
respondents, including the use of automated collection techniques or
other forms of information technology.
In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3521, AHRQ invites the public to comment on this proposed information
collection. This is a second review opportunity.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-03463 Filed 2-21-17; 8:45 am]
BILLING CODE 4160-90-P